The goal of the Geisinger MyCode™ Community Health Initiative is to recruit and consent most Geisinger patients. Patient samples will be sequenced and the data combined with each participant's medical record to allow Geisinger researchers and research partners to investigate new approaches to disease prevention, diagnosis and treatment.
Working in partnership with Geisinger's large patient population, MyCode™ Community Health Initiative will increase our understanding of chronic diseases and potentially lead to new treatments.
MyCode™ Community Health Initiative participants agree to allow their genomic information and electronic health records to be studied. All records are assigned a coded number to protect participant identity.
Studying the Future of Disease
Geisinger researchers discuss MyCode and the collaboration with Regeneron.